Drugs / Hua Yu Wan
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT07658807 | Jun 2026 → Feb 2028 expected | arterial occlusion, diabetic peripheral angiopathy, peripheral arterial disease | Xuanwu Hospital, Beijing | Not yet recruiting | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Hua Yu Wan | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07658807 ↗ |
| Known as | Hua Yu Wan Capsule | “specifically the capsule form called Hua Yu Wan Capsule” NCT07658807 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “A modern preparation of the classic Traditional Chinese Medicine formula Bu Yang Huanwu Decoction” NCT07658807 ↗ |
| Route | Oral | “Dosage and Route: 2 capsules, taken orally three times daily” NCT07658807 ↗ |